Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumor in vitro and in vivo
Nanotechnology. 2010 Nov 26;21(47):475101.
Sun M1, Wang Y, Shen J, Xiao Y, Su Z, Ping Q.
Octreotide-polietilene glicole-fosfatidiletanolamina per il riconoscimento di liposomi doxorubicina-caricati nei tumori del melanoma e del pancreas.
Octreotide-doxorubicina/tumori del melanoma e del pancreas.